Augmentation of SSRI or SNRI treatment with the glutamatergic modulator riluzole may selectively improve hyperarousal symptoms in combat veterans with PTSD, according to a study in the Journal of Clinical Psychiatry.
A new MAPS study estimates that payers making MDMA-assisted psychotherapy available to 1,000 patients for the treatment of post-traumatic stress disorder would cut healthcare costs by $103.2 million over 30 years.
It's normal for a pandemic to propagate fear in both adults and children or manifest confusion or anger. However, when these feelings don't go away, adults, children and front-line workers may have PTSD. Here’s what to look for.
Although many treatment centers are under-resourced, Jamie Marich, PhD, LPCC-S, LICDC-CS, REAT, RYT-200, said in her NCAD session that trauma must be addressed as a root cause of many addiction disorders.
At Elevate by Psych Congress, Albert “Skip” Rizzo, PhD, will discuss the current state of simulation technology and address whether he believes clinical virtual reality is truly ready for the practice setting.
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.